Upcoming event
Masterclass on Non-muscle-invasive bladder cancer
Back

Overall survival (OS) by circulating tumor DNA (ctDNA) status in patients with post-operative muscle-invasive urothelial carcinoma (MIUC) treated with atezolizumab (atezo): update from IMvigor010

2022-07-12

Prof. Jürgen Gschwend updates us on the current findings of the IMvigor010 trial which he presented at EAU22.

Watch his presentation here.

Tags: EAU22